Assessment and Management of Newly Diagnosed Classical Hodgkin Lymphoma: A Consensus Practice Statement from the Australasian Lymphoma Alliance.

Author(s)
Cochrane, T
Campbell, B A
Gangatharan, S A
Latimer, M
Khor, R
Christie, Drh
Gilbertson, M
Ratnasingam, S
Palfreyman, Emma
Lee, H P
Trotman, J
Hertzberg, M
Dickinson, M
Publication Date
2021-09-09
Abstract
The management of Hodgkin Lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment related morbidity is a constant source of concern, for physicians and patients alike. PET adapted therapy has been developed for both early and advanced stage HL to try and improve the outcome of treatment, whilst minimising toxicities. The aim of this review is to digest the plethora of studies recently conducted and provide some clear, evidence-based practice statements to simplify the management HL. This article is protected by copyright. All rights reserved.
Pubmed ID
https://pubmed.ncbi.nlm.nih.gov/34505342/?otool=iaurydwlib
Link
Title
Assessment and Management of Newly Diagnosed Classical Hodgkin Lymphoma: A Consensus Practice Statement from the Australasian Lymphoma Alliance.
Type of document
Journal Article
Entity Type
Publication

Files:

NameSizeformatDescriptionLink
https://digitallibrary.health.nt.gov.au/nthealthserver/api/core/items/6733213e-776e-4733-9a0c-def1fb97aade